 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/16/2020 |
$2.89 |
$2.94 |
$2.83 |
$2.90 |
37.90K | | 10/19/2020 |
$2.90 |
$2.98 |
$2.87 |
$2.96 |
29.80K | | 10/20/2020 |
$2.95 |
$2.95 |
$2.76 |
$2.80 |
69.80K | | 10/21/2020 |
$2.85 |
$2.88 |
$2.75 |
$2.77 |
32.60K | | 10/22/2020 |
$2.75 |
$2.79 |
$2.66 |
$2.75 |
62.80K |
|
|
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of induced Vasomotor Symptoms where Hormone Replacement Therapy is likely contraindicated. |
|
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on October 16, 2020, ACER opened at $2.89, traded as high as $2.94 and as low as $2.83, and closed at $2.90. Trading volume was a total of 37.90K shares. On October 19, 2020, ACER opened at $2.90, traded as high as $2.98 and as low as $2.87, and closed at $2.96. Trading volume was a total of 29.80K shares. On October 20, 2020, ACER opened at $2.95, traded as high as $2.95 and as low as $2.76, and closed at $2.80. Trading volume was a total of 69.80K shares. On October 21, 2020, ACER opened at $2.85, traded as high as $2.88 and as low as $2.75, and closed at $2.77. Trading volume was a total of 32.60K shares. On October 22, 2020, ACER opened at $2.75, traded as high as $2.79 and as low as $2.66, and closed at $2.75. Trading volume was a total of 62.80K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/25/2010 |
|
| End date: |
10/22/2020 |
|
| Start price/share: |
$15.73 |
|
| End price/share: |
$2.75 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-82.52% |
|
| Average Annual Total Return: |
-16.00% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,749.01 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 10/16/2020 | $2.90 | | 10/19/2020 | $2.96 | | 10/20/2020 | $2.80 | | 10/21/2020 | $2.77 | | 10/22/2020 | $2.75 |
|
|
